First, among ACSL family members, AA treatment markedly and selectively reduced ACSL4 protein levels without affecting cellular levels of ACSL1 and ACSL5 in model hepatoma cell lines, including HepG2 and Huh7 cells as well as in primary mouse hepatocytes. This evidence concerns the gene ACSL5 and hepatocellular carcinoma.